Add to ORKGtrial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cance
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or...
Objective: The purpose of the study is to compare two taxanes/cisplatin combinations for metastatic ...
Abstract Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically...
Abstract Introduction The purpose of this investigati...
Byrski and colleagues present the results of a prospective phase II study of cisplatin in BRCA1-rela...
The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic...
III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamid...
The identification of patients with metastatic triple-negative breast cancer (mTNBC) who are expecte...
Cabozantinib (XL184), a multi-targeted oral tyrosine kinase inhibitor with activity against MET, VEG...
1. The journal Clinical Cancer Research is the original source of the material.2. This article is ho...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or...
Objective: The purpose of the study is to compare two taxanes/cisplatin combinations for metastatic ...
Abstract Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically...
Abstract Introduction The purpose of this investigati...
Byrski and colleagues present the results of a prospective phase II study of cisplatin in BRCA1-rela...
The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic...
III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamid...
The identification of patients with metastatic triple-negative breast cancer (mTNBC) who are expecte...
Cabozantinib (XL184), a multi-targeted oral tyrosine kinase inhibitor with activity against MET, VEG...
1. The journal Clinical Cancer Research is the original source of the material.2. This article is ho...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or...
Objective: The purpose of the study is to compare two taxanes/cisplatin combinations for metastatic ...
Abstract Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically...